CN1539454A - 板蓝根制剂及其质量控制方法 - Google Patents
板蓝根制剂及其质量控制方法 Download PDFInfo
- Publication number
- CN1539454A CN1539454A CNA031356885A CN03135688A CN1539454A CN 1539454 A CN1539454 A CN 1539454A CN A031356885 A CNA031356885 A CN A031356885A CN 03135688 A CN03135688 A CN 03135688A CN 1539454 A CN1539454 A CN 1539454A
- Authority
- CN
- China
- Prior art keywords
- radix isatidis
- preparation
- adenosine
- eye drop
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000010231 banlangen Substances 0.000 title claims abstract description 112
- 238000000034 method Methods 0.000 title claims description 30
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims abstract description 120
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims abstract description 60
- 229960005305 adenosine Drugs 0.000 claims abstract description 60
- 239000003814 drug Substances 0.000 claims abstract description 43
- 238000003908 quality control method Methods 0.000 claims abstract description 12
- 239000000284 extract Substances 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims description 73
- 239000003889 eye drop Substances 0.000 claims description 46
- 239000012567 medical material Substances 0.000 claims description 35
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 29
- 238000012360 testing method Methods 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 22
- 239000000243 solution Substances 0.000 claims description 22
- 239000008187 granular material Substances 0.000 claims description 14
- 238000002347 injection Methods 0.000 claims description 11
- 239000007924 injection Substances 0.000 claims description 11
- 239000011550 stock solution Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 239000012071 phase Substances 0.000 claims description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- 239000000499 gel Substances 0.000 claims description 6
- 239000013558 reference substance Substances 0.000 claims description 6
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000006188 syrup Substances 0.000 claims description 5
- 235000020357 syrup Nutrition 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 229910021529 ammonia Inorganic materials 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 238000004587 chromatography analysis Methods 0.000 claims description 2
- 238000010812 external standard method Methods 0.000 claims description 2
- 239000007791 liquid phase Substances 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 41
- 229940079593 drug Drugs 0.000 description 29
- CRDNMYFJWFXOCH-YPKPFQOOSA-N (3z)-3-(3-oxo-1h-indol-2-ylidene)-1h-indol-2-one Chemical compound N/1C2=CC=CC=C2C(=O)C\1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-YPKPFQOOSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 18
- 239000000706 filtrate Substances 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 15
- 230000000844 anti-bacterial effect Effects 0.000 description 15
- 238000000605 extraction Methods 0.000 description 15
- 239000001963 growth medium Substances 0.000 description 11
- 238000004321 preservation Methods 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 229920001817 Agar Polymers 0.000 description 9
- CRDNMYFJWFXOCH-BUHFOSPRSA-N Couroupitine B Natural products N\1C2=CC=CC=C2C(=O)C/1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-BUHFOSPRSA-N 0.000 description 9
- 239000008272 agar Substances 0.000 description 9
- 238000003556 assay Methods 0.000 description 9
- CRDNMYFJWFXOCH-UHFFFAOYSA-N isoindigotin Natural products N1C2=CC=CC=C2C(=O)C1=C1C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-UHFFFAOYSA-N 0.000 description 9
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 8
- 229940097275 indigo Drugs 0.000 description 8
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 235000010603 pastilles Nutrition 0.000 description 7
- 241000588747 Klebsiella pneumoniae Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 231100000915 pathological change Toxicity 0.000 description 6
- 230000036285 pathological change Effects 0.000 description 6
- 229960004150 aciclovir Drugs 0.000 description 5
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 239000010985 leather Substances 0.000 description 5
- 238000004064 recycling Methods 0.000 description 5
- 238000013112 stability test Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 4
- 230000001986 anti-endotoxic effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000001508 eye Anatomy 0.000 description 4
- 229940012356 eye drops Drugs 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 241000588624 Acinetobacter calcoaceticus Species 0.000 description 3
- 241000334154 Isatis tinctoria Species 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000003285 pharmacodynamic effect Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000001568 sexual effect Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000588697 Enterobacter cloacae Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000334160 Isatis Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 241000700584 Simplexvirus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000257673 Strobilanthes cusia Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 102000011759 adducin Human genes 0.000 description 2
- 108010076723 adducin Proteins 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000001408 fungistatic effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001360526 Escherichia coli ATCC 25922 Species 0.000 description 1
- 208000005100 Herpetic Keratitis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010073938 Ophthalmic herpes simplex Diseases 0.000 description 1
- 241000589614 Pseudomonas stutzeri Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000016150 acute pharyngitis Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003460 anti-nuclear Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 108010079058 casein hydrolysate Proteins 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000004349 growth plate Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000003808 methanol extraction Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000005325 percolation Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007560 sedimentation technique Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
Abstract
Description
细菌(编号) | MIC值(mg/ml) | MBC值(mg/ml) |
大肠杆菌0216 | 250 | >250 |
ESBLs大肠02-3 | >250 | >250 |
金葡球菌02222 | 62.5 | >250 |
金葡球菌02216 | 62.5 | >250 |
肺克02-9-7 | >250 | >250 |
不动02511 | 125 | >250 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031356885A CN100352458C (zh) | 2003-08-29 | 2003-08-29 | 板蓝根制剂及其质量控制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031356885A CN100352458C (zh) | 2003-08-29 | 2003-08-29 | 板蓝根制剂及其质量控制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1539454A true CN1539454A (zh) | 2004-10-27 |
CN100352458C CN100352458C (zh) | 2007-12-05 |
Family
ID=34323193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031356885A Expired - Lifetime CN100352458C (zh) | 2003-08-29 | 2003-08-29 | 板蓝根制剂及其质量控制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100352458C (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101403731A (zh) * | 2008-10-30 | 2009-04-08 | 武汉康裕医药科技有限公司 | 板蓝大青颗粒含量测定方法 |
CN101716215B (zh) * | 2009-12-21 | 2011-08-03 | 中国科学院长春应用化学研究所 | 一种中药板蓝根的质量检测方法 |
CN103520227A (zh) * | 2013-10-09 | 2014-01-22 | 南京农业大学 | 一种板蓝根注射用原位凝胶及其制备方法 |
CN104297402A (zh) * | 2014-07-22 | 2015-01-21 | 吉林大学 | 车前子中腺嘌呤核苷的hplc含量测定方法 |
CN105372400A (zh) * | 2015-12-17 | 2016-03-02 | 江西汇仁药业有限公司 | 一种中药质量控制方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1056070C (zh) * | 1995-07-21 | 2000-09-06 | 乌鲁木齐市中亚实业有限公司 | 板蓝根糖浆的制作方法 |
CN1054987C (zh) * | 1996-04-25 | 2000-08-02 | 黎子正 | 一种用于治疗白内障的眼液及其生产工艺 |
CN1318399A (zh) * | 2000-04-18 | 2001-10-24 | 十堰康迪制药厂 | 板蓝根注射液及其制备方法 |
CN1277041A (zh) * | 2000-04-27 | 2000-12-20 | 王洪福 | 无糖型板蓝根制剂 |
-
2003
- 2003-08-29 CN CNB031356885A patent/CN100352458C/zh not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101403731A (zh) * | 2008-10-30 | 2009-04-08 | 武汉康裕医药科技有限公司 | 板蓝大青颗粒含量测定方法 |
CN101403731B (zh) * | 2008-10-30 | 2014-07-23 | 武汉康裕医药科技有限公司 | 板蓝大青颗粒含量测定方法 |
CN101716215B (zh) * | 2009-12-21 | 2011-08-03 | 中国科学院长春应用化学研究所 | 一种中药板蓝根的质量检测方法 |
CN103520227A (zh) * | 2013-10-09 | 2014-01-22 | 南京农业大学 | 一种板蓝根注射用原位凝胶及其制备方法 |
CN104297402A (zh) * | 2014-07-22 | 2015-01-21 | 吉林大学 | 车前子中腺嘌呤核苷的hplc含量测定方法 |
CN104297402B (zh) * | 2014-07-22 | 2016-01-20 | 吉林大学 | 车前子中腺嘌呤核苷的hplc含量测定方法 |
CN105372400A (zh) * | 2015-12-17 | 2016-03-02 | 江西汇仁药业有限公司 | 一种中药质量控制方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100352458C (zh) | 2007-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103768112B (zh) | 一种芒果叶提取物及其应用 | |
CN105983015B (zh) | 一种含有水飞蓟宾、ve的药物组合物 | |
CN1872106A (zh) | 山香圆叶在治疗病毒性感冒疾病中的应用 | |
CN1313086C (zh) | 一种注射用细辛脑制剂及制备方法 | |
CN1539454A (zh) | 板蓝根制剂及其质量控制方法 | |
CN1915986A (zh) | 一种高纯度的丹参酮iia磺酸钠、制备方法及其制剂 | |
CN1895296A (zh) | 一种检测灵芝产品口服制剂质量的方法 | |
CN1806820A (zh) | 一种中药组合物及其制备方法和质量控制方法 | |
CN1202067C (zh) | 药用级枸橼酸铁的制备方法 | |
CN1235581C (zh) | 一种龙血竭总黄酮制剂的制备方法及其质量控制方法 | |
CN105534937A (zh) | 一种头孢羟氨苄片剂及其制备方法 | |
CN1857497A (zh) | 一种中药消糜软膏剂及其质量控制方法 | |
CN1290557C (zh) | 一种治疗白内障的药物及其制备方法 | |
CN1853655A (zh) | 一种治疗溃疡性结肠炎的口服结肠靶向制剂及其制备方法 | |
CN1682969A (zh) | 一种药物组合物及其制备方法和质量控制方法 | |
CN1843352A (zh) | 一种米格列奈钙新制剂配方 | |
CN1772089A (zh) | 一种含有白花蛇舌草冻干粉针剂及其制备方法 | |
CN1220510C (zh) | 一种益气补血养心安神的中成药及其制备方法质量控制方法 | |
CN1931337A (zh) | 金刚藤微丸及其制备方法 | |
JP6116539B2 (ja) | ポリペプチドを含有する生体内で多くの効果を有する医薬組成物及びその用途 | |
CN112237632A (zh) | 一种人参基薄膜包衣材料的制备方法 | |
CN1973877A (zh) | 一种水菖蒲有效部位提取物及其用途 | |
CN110200980A (zh) | 一种荷载青蒿素的柑橘果胶的口服纳米粒子 | |
CN1355022A (zh) | 枸杞多糖在制备治疗脂肪肝药物中的应用 | |
CN1466951A (zh) | 栀子环烯醚萜总提物药物组合物制剂及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160105 Address after: 610000 No. 1, No. 5, building 14, nine Hing Road, Chengdu hi tech Zone, Sichuan, 903 Patentee after: Chengdu Bandung Yikang Pharmaceutical Co.,Ltd. Address before: 4, building 16, building B, Torch Hotel, No. 610041, Pioneer Road, hi tech Zone, Sichuan, Chengdu Patentee before: Chengdu Saymed Institute of Traditional Chinese Medicine |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160301 Address after: 850000 office building 110, Lhasa economic and Technological Development Zone, Tibet Autonomous Region Patentee after: Tibet Xinyi Kang Pharmaceutical Holdings Ltd. Address before: 610000 No. 1, No. 5, building 14, nine Hing Road, Chengdu hi tech Zone, Sichuan, 903 Patentee before: Chengdu Bandung Yikang Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20180814 Address after: 611630 301 industrial North Road, Pujiang Industrial Development Zone, Pujiang County, Chengdu, Sichuan Patentee after: Sichuan Heyi Pharmaceutical Co.,Ltd. Address before: 850000 110 office building, Lhasa Municipal Economic and Technological Development Zone, Tibet Autonomous Region Patentee before: Tibet Xinyi Kang Pharmaceutical Holdings Ltd. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Isatis root preparation and quality control method thereof Effective date of registration: 20200430 Granted publication date: 20071205 Pledgee: Bank of Chengdu science and technology branch of Limited by Share Ltd. Pledgor: Sichuan Heyi Pharmaceutical Co.,Ltd. Registration number: Y2020510000045 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210802 Granted publication date: 20071205 Pledgee: Bank of Chengdu science and technology branch of Limited by Share Ltd. Pledgor: Sichuan Heyi Pharmaceutical Co.,Ltd. Registration number: Y2020510000045 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Radix Isatidis preparation and its quality control method Effective date of registration: 20220624 Granted publication date: 20071205 Pledgee: Zhejiang Mintai commercial bank Limited by Share Ltd. Chengdu Gaoxin Branch Pledgor: Sichuan Heyi Pharmaceutical Co.,Ltd. Registration number: Y2022510000171 |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20071205 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20231107 Granted publication date: 20071205 Pledgee: Zhejiang Mintai commercial bank Limited by Share Ltd. Chengdu Gaoxin Branch Pledgor: Sichuan Heyi Pharmaceutical Co.,Ltd. Registration number: Y2022510000171 |